Heart rate as a therapeutic target in heart failure?

被引：10
|
作者：
Tavazzi, L [1 ]
机构：
[1] Inst Care Res, Dept Cardiol, Policlin San Matteo, Pavia, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2003年 / 5卷 / 0G期
关键词：
heart rate; heart failure; I-f channel; I-f channel antagonist; ivabradine;
D O I：
10.1016/S1520-765X(03)90003-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A common finding in all clinical trials on heart failure is a negative correlation between heart rate and duration of life. In several studies this was found in both patients taking and those not taking beta-blocker agents. In postinfarct patients increasing mortality with increasing heart rate was found in the absence and in the presence of left ventricular dysfunction. Moreover beneficial effects of neurohormonal modulators were found to be greater in heart failure patients with higher heart rate. Thus heart rate can be considered a target for medical intervention, and therapeutic attempts focused on direct control of heart rate have a good rationale. (C) 2003 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：G15 / G18
页数：4
相关论文
共 50 条
  • [21] Heart rate variability in chronic heart failure: Target for therapy?
    Sueta, CA
    AMERICAN HEART JOURNAL, 2003, 146 (03) : 385 - 387
  • [22] Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties
    Dobre, Daniela
    Borer, Jeffrey S.
    Fox, Kim
    Swedberg, Karl
    Adams, Kirkwood F.
    Cleland, John G. F.
    Cohen-Solal, Alain
    Gheorghiade, Mihai
    Gueyffier, Francois
    O'Connor, Christopher M.
    Fiuzat, Mona
    Patak, Athul
    Pina, Ileana L.
    Rosano, Giuseppe
    Sabbah, Hani N.
    Tavazzi, Luigi
    Zannad, Faiez
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (01) : 76 - 85
  • [23] Morbid Obesity as a Therapeutic Target for Heart Failure
    Chonyang L. Albert
    Current Treatment Options in Cardiovascular Medicine, 2019, 21
  • [24] Endothelin in heart failure: A promising therapeutic target?
    Love, MP
    McMurray, JJV
    HEART, 1997, 77 (02) : 93 - 94
  • [25] Mitochondrial function as a therapeutic target in heart failure
    Brown, David A.
    Perry, Justin B.
    Allen, Mitchell E.
    Sabbah, Hani N.
    Stauffer, Brian L.
    Shaikh, Saame Raza
    Cleland, John G. F.
    Colucci, Wilson S.
    Butler, Javed
    Voors, Adriaan A.
    Anker, Stefan D.
    Pitt, Bertram
    Pieske, Burkert
    Filippatos, Gerasimos
    Greene, Stephen J.
    Gheorghiade, Mihai
    NATURE REVIEWS CARDIOLOGY, 2017, 14 (04) : 238 - 250
  • [26] Morbid Obesity as a Therapeutic Target for Heart Failure
    Albert, Chonyang L.
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2019, 21 (10)
  • [27] Worsening Heart Failure Challenges as a Therapeutic Target
    Tang, W. H. Wilson
    Grodin, Justin L.
    JACC-HEART FAILURE, 2015, 3 (05) : 404 - 407
  • [28] Phospholamban:: A promising therapeutic target in heart failure?
    Schmidt, AG
    Edes, I
    Kranias, EG
    CARDIOVASCULAR DRUGS AND THERAPY, 2001, 15 (05) : 387 - 396
  • [29] Phospholamban: A Promising Therapeutic Target in Heart Failure?
    Albrecht G. Schmidt
    Istvan Edes
    Evangelia G. Kranias
    Cardiovascular Drugs and Therapy, 2001, 15 : 387 - 396
  • [30] Heart failure: an underestimated therapeutic target in diabetes
    Marx, Nikolaus
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2018, 7 (01): : 10 - 12
12345